Pulmonary nodule laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no diagnostic laboratory findings associated with solitary pulmonary nodule.<ref name="pmid2019220">{{cite journal |vauthors=Lillington GA |title=Management of solitary pulmonary nodules |journal=Dis Mon |volume=37 |issue=5 |pages=271–318 |year=1991 |pmid=2019220 |doi= |url=}}</ref> | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
The use of biomarker may be useful in the risk stratification for solitary pulmonary nodule, biomarkers such as: | *The use of biomarker may be useful in the risk stratification for solitary pulmonary nodule, biomarkers such as: | ||
:*Carcinoembryonic antigen | :*Carcinoembryonic antigen | ||
:*Alpha-1 antitrypsin | :*Alpha-1 antitrypsin | ||
:*Squamous cell carcinoma antigen | :*Squamous cell carcinoma antigen | ||
The measurement of biomarkers may be useful for benign diseases, markers such as: | *The measurement of biomarkers may be useful for benign diseases, markers such as: | ||
:*Angiotensin converting enzyme | :*Angiotensin converting enzyme | ||
:*Connective tissue disease markers | :*Connective tissue disease markers |
Revision as of 22:41, 17 March 2016
Pulmonary Nodule Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary nodule laboratory findings On the Web |
American Roentgen Ray Society Images of Pulmonary nodule laboratory findings |
Risk calculators and risk factors for Pulmonary nodule laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]}Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
There are no diagnostic laboratory findings associated with solitary pulmonary nodule.[1]
Laboratory Findings
- The use of biomarker may be useful in the risk stratification for solitary pulmonary nodule, biomarkers such as:
- Carcinoembryonic antigen
- Alpha-1 antitrypsin
- Squamous cell carcinoma antigen
- The measurement of biomarkers may be useful for benign diseases, markers such as:
- Angiotensin converting enzyme
- Connective tissue disease markers